Fieldslassiter8281
Adenoviruses are large (~950 Å) and complex non-enveloped, dsDNA icosahedral viruses. They have a pseudo-T = 25 triangulation number with at least 12 different proteins composing the virion. These include the major and minor capsid proteins, core proteins, maturation protease, terminal protein, and packaging machinery. Although adenoviruses have been studied for more than 60 years, deciphering their architecture has presented a challenge for structural biology techniques. An outstanding event was the first near-atomic resolution structure of human adenovirus type 5 (HAdV-C5), solved by cryo-electron microscopy (cryo-EM) in 2010. Discovery of new adenovirus types, together with methodological advances in structural biology techniques, in particular cryo-EM, has lately produced a considerable amount of new, high-resolution data on the organization of adenoviruses belonging to different species. In spite of these advances, the organization of the non-icosahedral core is still a great unknown. Nevertheless, alternative techniques such as atomic force microscopy (AFM) are providing interesting glimpses on the role of the core proteins in genome condensation and virion stability. Here we summarize the current knowledge on adenovirus structure, with an emphasis on high-resolution structures obtained since 2010.Physical fatigue is a recurrent problem in running that negatively affects performance and leads to an increased risk of being injured. Identification and management of fatigue helps reducing such negative effects, but is presently commonly based on subjective fatigue measurements. Inertial sensors can record movement data continuously, allowing recording for long durations and extensive amounts of data. Here we aimed to assess if inertial measurement units (IMUs) can be used to distinguish between fatigue levels during an outdoor run with a machine learning classification algorithm trained on IMU-derived biomechanical features, and what is the optimal configuration to do so. Eight runners ran 13 laps of 400 m on an athletic track at a constant speed with 8 IMUs attached to their body (feet, tibias, thighs, pelvis, and sternum). Three segments were extracted from the run laps 2-4 (no fatigue condition, Rating of Perceived Exertion (RPE) = 6.0 ± 0.0); laps 8-10 (mild fatigue condition, RPE = 11.7 ± 2.0); laps 11-13 (heavy fatigue condition, RPE = 14.2 ± 3.0), run directly after a fatiguing protocol (progressive increase of speed until RPE ≥ 16) that followed lap 10. A random forest classification algorithm was trained with selected features from the 400 m moving average of the IMU-derived accelerations, angular velocities, and joint angles. A leave-one-subject-out cross validation was performed to assess the optimal combination of IMU locations to detect fatigue and selected sensor configurations were considered. RU58841 The left tibia was the most recurrent sensor location, resulting in accuracies ranging between 0.761 (single left tibia location) and 0.905 (all IMU locations). These findings contribute toward a balanced choice between higher accuracy and lower intrusiveness in the development of IMU-based fatigue detection devices in running.Myocardial infarction often leads to progressive structural and electrophysiologic remodeling of the left ventricle. Despite the widespread use of β-adrenergic blockade and implantable defibrillators, morbidity and mortality from chronic-phase ventricular tachyarrhythmias remains high, calling for further investigation on the underlying pathophysiology. Histological and functional studies have demonstrated extensive alterations of sympathetic nerve endings at the peri-infarct area and flow-innervation mismatches that create a highly arrhythmogenic milieu. Such accumulated evidence, along with the previously well-documented autonomic dysfunction as an important contributing factor, has stirred intense research interest for pharmacologic and non-pharmacologic neuromodulation in post-infarction heart failure. In this regard, aldosterone inhibitors, sacubitril/valsartan and sodium-glucose cotransporter type 2 inhibitors have shown antiarrhythmic effects. Non-pharmacologic modalities, currently tested in pre-clinical and clinical trials, include transcutaneous vagal stimulation, stellate ganglion modulation and renal sympathetic denervation. In this review, we provide insights on the pathophysiology of ventricular arrhythmogenesis post-myocardial infarction, focusing on sympathetic activation.Vaccine hesitancy has increased in the past few years, influenced by the socio-cultural differences, political populism, or concerns related to the effectiveness and safety of some vaccines, resulting a feeling of distrust. This feeling can become a barrier against the achievement of the immunity necessary to stop the expansion of COVID-19. The aim of this study was to evaluate the acceptance of the vaccine against COVID-19 in Spain, as well as to identify the factors that have an influence on the concerns and attitudes of people against accepting the vaccine in the months prior to the start of vaccination on December 2020. An online questionnaire was created to obtain information about (1) sociodemographic characteristics; (2) concerns and sources of information about vaccines; and (3) attitudes about vaccination and state of health. A multivariate logistic regression was performed to identify the influencing factors. Of the 2501 participants, 1207 (48.3%) would accept the COVID-19 vaccine, 623 (24.9%) were hesitant, and 671 (26.8%) would reject it. The logistic regression showed that being male, older than 60, married, retired, with a high level of education, or with a leftist political inclination, could increase the probability of accepting the COVID-19 vaccine. Disinformation and the lack of political consensus were the main sources of distrust. The patients with hypertension, immunodepression, hypercholesterolemia, or respiratory disease, or were overweight, showed a greater acceptance to the vaccine, while those with cancer took the longest to accept it. A low acceptance of the vaccine against COVID-19 was observed among the Spanish population in the phase prior to its availability, and the main fears of the population were identified. It is necessary to offer correct and transparent information about these vaccines to reduce the concerns and increase the trust of the population, to thereby guarantee the success of the vaccination campaigns.